2024 Rome, Italy

IV-053 Tamara van Donge
Middle-out physiologically-based pharmacokinetic modeling to support pediatric dosing recommendation for alectinib, an ALK tyrosine kinase receptor inhibitor
Thursday 15:00-16:30
IV-054 Tamara van Donge
Population PK modeling of Vamikibart in aqueous humor, an anti-IL-6 monoclonal antibody, in patients with diabetic and uveitic macular edema
Thursday 15:00-16:30